A study to test whether different combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 help people with head and neck cancer or liver cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512799-36-00

Acronym

1443-0002

Enrollment

Registered

2024-07-23

Start date

2022-04-12

Completion date

Unknown

Last updated

2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck squamous cell carcinoma (HNSCC), hepatocellular carcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026